EUVIMEDEUVIMED entdecken
Crossref

Feasibility of Simulated Low-Dose CT with Deep Learning Denoising for Lymphoma PET/CT Imaging: A Clinical Study on Lesion Detection, Staging, and Therapy Response

Yingming He, Huiyang Peng, Zhen Li, Wenxiang Zou, Feihe Xiang, Yilin Li, Xiaofeng Liu, Yafei Dong, Didi Chi, Wenbin Yang, Mantian Liao

Journal of Imaging Informatics in Medicine · 09.11.2026

DOI: 10.1007/s10278-026-02474-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Imaging Informatics in Medicine, online erschienen am 09.11.2026. Verfasst von Yingming He und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Xiangtan Central Hospital (The Affiliated Hospital of Hunan University), 120 Heping Road, Xiangtan, 411100, Hunan Pro…. Die Arbeit nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

[18F]FDG PET/CT is central to lymphoma staging and treatment-response assessment, but repeated examinations increase cumulative radiation exposure, largely from the CT component. This retrospective study included 152 patients with 211 whole-body PET/CT scans and evaluated whether deep learning-denoised simulated low-dose CT can preserve diagnostic performance. A single-scan cohort of 108 patients was used exclusively for model development, while an independent follow-up cohort of 44 patients (103 examinations) was reserved for quantitative evaluation and a fully crossed multi-reader, multi-case study. Simulated low-dose CT images ranging from 2/3 to 1/8 of the standard dose were reviewed, and the 1/4-dose level was selected as the lowest clinically acceptable level. A denoising model was trained using paired standard-dose CT (SDCT) and simulated low-dose CT at 1/4 of the standard dose (SLDCT) images. Six nuclear medicine physicians evaluated three imaging conditions: PET/CT with SDCT, PET/CT with SLDCT, and PET/CT with denoised SLDCT (D-SLDCT), for image quality, lesion detectability, staging, and treatment response. D-SLDCT significantly improved quantitative image quality compared with SLDCT (all p < 0.0001) and increased subjective image-quality scores (4.11 ± 0.46 vs 3.00 ± 0.00). Staging accuracy was lower under the SLDCT condition than under the SDCT condition (MAE, 1.50 ± 0.27 vs 1.40 ± 0.20; p = 0.0011), whereas the D-SLDCT condition did not differ significantly from the SDCT condition (MAE, 1.44 ± 0.22; p = 0.47). Differences were more pronounced in patients with BMI ≥ 24 kg/m2 and among junior readers. Lesion detectability and treatment-response assessment did not differ significantly across conditions, while within-reader lesion-detection agreement with the SDCT condition improved after denoising (κ = 0.72 vs 0.67). The D-SLDCT condition preserved diagnostic performance, supporting radiation-conscious lymphoma PET/CT. This study was registered with the Chinese Clinical Trial Registry (ChiCTR) on February 14, 2026 (registration number: ChiCTR2600119037).

Schlagwörter

Stichwörter der Autor:innen

Deep learningLow-dose CTLymphomaPET/CTTreatment response assessment

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Xiangtan Central Hospital (The Affiliated Hospital of Hunan University), 120 Heping Road, Xiangtan, 411100, Hunan Province, China.
  • Yale Biomedical Imaging Institute and Department of Radiology and Biomedical Imaging, Yale University, 333 Cedar Street, New Haven, CT, 06510, USA.
  • Department of Radiology, Xiangtan Central Hospital (The Affiliated Hospital of Hunan University), 120 Heping Road, Xiangtan, 411100, Hunan Province, China.
  • Department of Biomedical Informatics and Data Science, Yale University, 333 Cedar Street, New Haven, CT, 06510, USA.
  • Gastrointestinal Endoscopy Center, Xiangtan Central Hospital (The Affiliated Hospital of Hunan University), 120 Heping Road, Xiangtan, 411100, Hunan Province, China. ywbto@sohu.com.
  • Department of Nuclear Medicine, Xiangtan Central Hospital (The Affiliated Hospital of Hunan University), 120 Heping Road, Xiangtan, 411100, Hunan Province, China. 13786205976@163.com.

Zitieren

APA

He, Y., Peng, H., Li, Z., Zou, W., Xiang, F., Li, Y., Liu, X., Dong, Y., Chi, D., Yang, W., & Liao, M. (2026). Feasibility of Simulated Low-Dose CT with Deep Learning Denoising for Lymphoma PET/CT Imaging: A Clinical Study on Lesion Detection, Staging, and Therapy Response. Journal of Imaging Informatics in Medicine. https://doi.org/10.1007/s10278-026-02474-1

Vancouver

He Y, Peng H, Li Z, Zou W, Xiang F, Li Y, et al. Feasibility of Simulated Low-Dose CT with Deep Learning Denoising for Lymphoma PET/CT Imaging: A Clinical Study on Lesion Detection, Staging, and Therapy Response. Journal of Imaging Informatics in Medicine. 2026. doi:10.1007/s10278-026-02474-1

BibTeX
@article{He2026,
  author = {He, Yingming and Peng, Huiyang and Li, Zhen and Zou, Wenxiang and Xiang, Feihe and Li, Yilin and Liu, Xiaofeng and Dong, Yafei and Chi, Didi and Yang, Wenbin and Liao, Mantian},
  title = {Feasibility of Simulated Low-Dose CT with Deep Learning Denoising for Lymphoma PET/CT Imaging: A Clinical Study on Lesion Detection, Staging, and Therapy Response},
  journal = {Journal of Imaging Informatics in Medicine},
  year = {2026},
  doi = {10.1007/s10278-026-02474-1}
}
Kostenlos starten →